Clinical Trial Update: Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients

View source ↗

Summary

This document summarizes a real-world evaluation of sotorasib in Chinese patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• sotorasib (sotorasib)

Snippet

Sponsor: Amgen | Conditions: Non-Small Cell Lung Cancer | Status: COMPLETED